The quick read
Latest quote·Oct 15
Net selling: insiders sold $12.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $16K to $65K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $12.7M and bought $0 of DHR stock on the open market in the 90 days to Oct 16, 2026, according to SEC Form 4 filings. The largest was Blair, Rainer (President & CEO), who sold $12.7M. The latest filing was on Aug 24, 2026.
Rep. Kevin Hern (R) sold $1K to $15K on Sep 2, 2026, disclosed 23 days later. Rep. Kevin Hern (R) sold $15K to $50K on Aug 31, 2026, disclosed 25 days later. In total, 1 member disclosed 2 DHR trades with trade dates in the last 180 days, filed a median 24 days after trading.
This summary uses filings available on Oct 16, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Millennium
$373.1M
added
Sells/Trims (2)
Two Sigma
$266.2M
trimmed
D.E. Shaw
$192.3M
trimmed
Sells (2)
Blair Rainer
$12.7M
sold
Spoon Alan G
$237K
sold
Buys (1)
Sells (2)
No tracked top-trader positions in DHR right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 21, 2026
Financial period
Q2 2026
Adjusted EPS
$1.84 expected
Revenue
No comparable estimate
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 20, 2026 | $1.94 / $1.84Yahoo Finance | +5.28% beat | $6.26B / Unavailable | Unavailable |
| Mar 31, 2026 | Apr 21, 2026 | $2.06 / $1.94Yahoo Finance | +6.45% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Jan 28, 2026 | $2.23 / $2.19Yahoo Finance | +1.99% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 21, 2025 | $1.89 / $1.72Yahoo Finance | +9.78% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 22, 2025 | $1.80 / $1.64Alpha Vantage | +9.76% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 22, 2025 | $1.88 / $1.64Alpha Vantage | +14.63% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Jan 29, 2025 | $2.14 / $2.16Alpha Vantage | -0.93% in line | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 22, 2024 | $1.71 / $1.57Alpha Vantage | +8.92% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 16, 2026
EPS expected
$1.89 to $1.99
Revenue expected
19 analysts
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.05B | $6.84B | $5.95B | $6.26B |
| Cost of what it sold | $2.53B | $2.87B | $2.36B | $2.65B |
| Gross profit | $3.52B | $3.97B | $3.59B | $3.61B |
| What it spent | ||||
| Research and development | $378.0M | $438.0M | $387.0M | $412.0M |
| Sales and admin | $1.99B | $2.03B | $1.86B | $2.07B |
| Total operating expenses | $2.37B | $2.46B | $2.25B | $2.48B |
| What was left | ||||
| Operating profit | $1.15B | $1.50B | $1.34B | $1.13B |
| Interest on debt | $67.0M | $55.0M | $63.0M | $107.0M |
| Profit before tax | $1.08B | $1.37B | $1.24B | $1.08B |
| Tax | $168.0M | $176.0M | $206.0M | $208.0M |
| Net profit | $908.0M | $1.20B | $1.03B | $870.0M |
| EBITDA | $1.76B | $2.05B | $1.93B | $1.84B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Morgan Stanley lifts target for Mettler-Toledo stock to USD 1,575.00
NeutralOct 15Danaher Corp Stock (DHR) Moved Up by 3.34% on Oct 15: Drivers Behind the Movement
Leans bullishOct 15Royal Bank of Canada cuts target for Fortive stock to USD 59.00
Leans bullishOct 15Bio-Techne stock sits 0.22 percent below its 52-week high
NeutralOct 15Danaher partners with NVIDIA and Danaher stock costs EUR 202.55 on October 15, 2026 best-effort
BullishOct 15For no consideration, Danaher (DHR)’s executive committee chairman waives a stock award.
NeutralOct 14For no consideration, Danaher (DHR) chairman waives his stock award.
NeutralOct 14Bruker, Sotera downgraded as J.P. Morgan reviews life sciences coverage
NeutralOct 14